23
APRIL 24
TH
– 26
TH
, 2014 | OLOMOUC | THE CZECH REPUBLIC
I NV I T ED GUE S T S
Zoran Culig, Associate Professor, M.D., Ph.D.
Personal data, address, home page: Nationality: Austrian. Address (business): Department
of Urology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria. Phone
(business): 0043 512 504 24717. Fax: 0043 512 504 24817. E-mail:
Address (private): Schneeburggasse 89, A-6020 Innsbruck, Austria. Phone (private): 0043
512 280023. Phone (mobile): 0043 699 1151 6998. Home page:
Research area: Major research interests: molecular endocrinology of advanced prostate
cancer, interactions between signaling pathways of cytokines, growth factors and androgen
receptor, expression and function of androgen receptor in advanced prostate disease,
regulation of prostate growth and function by interleukin-6, developing new experimental
therapies to interfere with androgen receptor and interleukin-6 signaling
Research career: Title: Associate Professor of Molecular Pathology, Innsbruck Medical
University, Austria. Degree: M.D., University of Zagreb, Republic of Croatia. Birth date: March
18th, 1965 in Zagreb, Republic of Croatia. Education: Primary school, Zagreb, 1971–1979.
Secondary school, Zagreb, 1979–1983. School of Medicine, Zagreb, 1984–1990. Professional
career: Research Associate, Department of Urology, Univ. of Innsbruck 1991–1995. University
Assistant, Department of Urology, Univ. of Innsbruck 1995–1999. Associate Professor
of Molecular Pathology, Department of Urology, Univ. of Innsbruck/Innsbruck Medical
University 1999–present. External professorship invitations: Charite, University Hospital
Berlin.
Awards and honors: Invited lectures (5 most important). Scientific awards (5 most important).
Reviewer/Editorial Board Member (5 most important). Research funding (5 most important).
International collaborators (5 most important).
Olivier Cuvillier, MSc., Ph.D.
Olivier Cuvillier gained the M.Sc. degree in Biochemistry in 1990 and the Ph.D. degree
in Ph.D in Biochemistry in 1994, both at the University of Sciences and Technologies of
Lille, France. He is currently the head at the Sphingolipids & Cancer Research Laboratory,
Institut de Pharmacologie et Biologie Structurale, Toulouse. He is interested in sphingolipid
metabolism, signal transduction, angiogenesis, hypoxia, prostate cancer, kidney cancer,
bone metastasis and chemoprevention. He is an author of more than 42 original papers
and more than 30 reviews and book chapters. Dr. Cuvillier is a reviwer and expert for
55 peer-reviewed journals (Nat Reviews Cancer, Blood, Cancer Res, Faseb J, Leukemia,
Oncogene, PloS One, Mol Cancer Ther, Cancer Prev Res, Int J Cancer, etc.) and 19 research
agencies and charities from 11 different countries (France, UK, Belgium, Italy, Switzerland,
Chyprus, Austria, Czech Republic, Russia, Singapore, Hong Kong). He is a member of New
York Academy of Sciences, French Society of Angiogenesis, European Association for
Cancer Research, French Cancer Society, American Association for Cancer Research and
French Society for Biochemistry and Molecular Biology.
